-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Titan Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Titan Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.09M, a 32% decline year-over-year.
- Titan Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$5.46M, a 35.5% increase year-over-year.
- Titan Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$5.57M, a 45.4% increase from 2022.
- Titan Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$10.2M, a 16.3% decline from 2021.
- Titan Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$8.78M, a 51.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)